Stifel Reiterates Buy Rating, $10 Price Target on Applied Genetic Technologies (AGTC), Sees Potential for Significant Upside from SKYLINE Trial Readout
Tweet Send to a Friend
Stifel analyst Dae Gon Ha reiterated a Buy rating and $10.00 price target on Applied Genetic Technologies Corp. (NASDAQ: AGTC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
